Sanofi and its partner, Orano Med, announced on October 25, 2023, that their alpha-emitting radiopharmaceutical candidate has achieved a significant milestone in its Phase 2 clinical...
The U.S. Food and Drug Administration (FDA) has issued new draft guidance that mandates the inclusion of overall survival (OS) data in all randomized clinical trials...
The U.S. Food and Drug Administration (FDA) has issued new draft guidance requiring that overall survival (OS) data be included in all randomized cancer drug clinical...
